Aimei Health Technology (AFJK) Liabilities and Shareholders Equity (2023 - 2025)

Aimei Health Technology (AFJK) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $12.1 million in Q4 2025.

• On a quarterly basis, Liabilities and Shareholders Equity fell 83.6% year-over-year to $12.1 million in Q4 2025; TTM through Dec 2025 was $145.7 million, a 49.71% decrease from a year earlier, with the FY2025 full-year figure at $12.1 million, down 83.6% from the prior year.
• Liabilities and Shareholders Equity for Q4 2025 stood at $12.1 million, down from $45.5 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for AFJK reached as high as $73.8 million in Q4 2024 and fell as low as $12.1 million in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $56.2 million across 3 years, with a median of $70.5 million in 2023.
• Across the five-year window, Liabilities and Shareholders Equity gained 4.75% in 2024 and plunged 83.6% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $70.5 million in 2023, then climbed by 4.75% to $73.8 million in 2024, then plunged by 83.6% to $12.1 million in 2025.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $12.1 million in Q4 2025, $45.5 million in Q3 2025, and $44.6 million in Q2 2025.